日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antioxidant Activity of Maillard Reaction Products in Dairy Products: Formation, Influencing Factors, and Applications

乳制品中美拉德反应产物的抗氧化活性:形成、影响因素及应用

Lan, Hong; Xu, Jinjing; Lu, Xiaolong; Hu, Xinyue; Peng, Liteng; Liu, Qingyou; Ye, Fei; Qi, Hao

Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy

筛选适合接受钇-90微球选择性内放射治疗的肝癌患者人群

Liang, Licong; Liang, Yuchan; Huang, Wensou; Guo, Yongjian; Huang, Jingjun; Zhou, Jingwen; Lin, Liteng; Nie, Xinxin; Cai, Mingyue; Zhu, Kangshun

SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation

SARS-CoV-2 NSP14抑制剂具有强大的抗病毒活性,并能逆转NSP14驱动的宿主调控。

Mengxin Luo # ,Jun Mo # ,Ziqiao Wang # ,Huimin Wei ,Kexin Chen ,Liteng Shen ,Ying Wang ,Linjie Li ,Yongkang Chen ,Weihao Chen ,Xue Li ,Hui Feng ,Xinyu Wang ,Huan Zhou ,Bizhi Li ,Feng Xu ,Qingwei Zhao ,Yichen Xu ,Jinxin Che ,Peng Zou ,Rong Zhang ,Xiaowu Dong ,Wei Xie

SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study

SIRT 或 TACE 联合乐伐替尼和 PD-(L)1 抑制剂治疗高肿瘤负荷肝细胞癌:一项多中心、回顾性、倾向评分匹配研究

Huang, Jingjun; Niu, Huimin; Zhang, Hui; Cai, Mingyue; Wang, Zhiheng; Guo, Yongjian; Liang, Licong; Lin, Liteng; Yang, Tingqi; Huang, Jiabai; Liang, Yuchan; Guo, Zhaoxiong; Zhou, Jingwen; Huang, Wensou; Zhu, Kangshun

Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study

索拉非尼联合替雷利珠单抗和经动脉化疗栓塞术治疗晚期肝细胞癌:一项 II 期研究

Liang, Licong; Zhou, Jingwen; Huang, Jingjun; Guo, Yongjian; Zhou, Zhimei; Chen, Ye; Lin, Liteng; Hong, Xiaoyang; Shi, Wenbo; Lin, Zhaoyi; Liu, Juan; Zhu, Kangshun; Huang, Wensou; Cai, Mingyue

Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial

多那非尼联合信迪利单抗治疗晚期肝细胞癌:一项单臂 II 期试验

Hong, Xiaoyang; Guo, Yongjian; Shi, Wenbo; Zhu, Kangshun; Liang, Licong; Lin, Liteng; Chen, Ye; Zhou, Jingwen; Huang, Jingjun; Huang, Jiabai; Wu, Yaozhu; Huang, Wensou; Cai, Mingyue

Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation

柴胡皂苷B1通过阻断STAT3/Gli1相互作用和诱导Gli1降解来减轻肝纤维化

Shao, Meiyu; Zhang, Xiaoqing; Sun, Jiamei; Dong, Hongyan; Han, Xin; Yang, Qiao; Chen, Roufen; Shen, Liteng; Xu, Lei; Wang, Lu; Zhu, Bo; Tang, Dongxin; Zhang, Shuosheng; Lu, Keda; Peng, Mengyun; Cao, Gang

Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation

人工智能α折叠模型在分子生物学和药物发现中的应用:一项基于机器学习的信息学研究

Guo, Song-Bin; Meng, Yuan; Lin, Liteng; Zhou, Zhen-Zhong; Li, Hai-Long; Tian, Xiao-Peng; Huang, Wei-Juan

ADCdb: the database of antibody-drug conjugates

ADCdb:抗体药物偶联物数据库

Shen, Liteng; Sun, Xiuna; Chen, Zhen; Guo, Yu; Shen, Zheyuan; Song, Yi; Xin, Wenxiu; Ding, Haiying; Ma, Xinyue; Xu, Weiben; Zhou, Wanying; Che, Jinxin; Tan, Lili; Chen, Liangsheng; Chen, Siqi; Dong, Xiaowu; Fang, Luo; Zhu, Feng

Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study

乐伐替尼联合载药微球经动脉化疗栓塞术(伴或不伴肝动脉灌注化疗)治疗伴有门静脉主要肿瘤血栓形成的大于7厘米的肝细胞癌:一项多中心回顾性队列研究

Cai, Mingyue; Liang, Licong; Zhang, Jian; Chen, Nianping; Huang, Wensou; Guo, Yongjian; Hong, Xiaotao; Lin, Liteng; Liu, Yaohong; Dan, Cao; Deng, Haihui; Liu, Xiaoguang; Zhou, Jingwen; Chen, Ye; Chen, Huanwei; Zhu, Kangshun